SEC Tracker
Get the app

Silexion Therapeutics SLXN

Silexion Therapeutics approves share changes

Item 5.03 Amends charter or bylaws, Item 5.07 Shareholder vote results

Form
8-K
Filed
Importance
Notable
  1. 2,697,489 shares voted, 18.6% of total
  2. 95.4% voted for share capital increase
  3. 97.7% voted for reverse split proposal

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Silexion Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025
  2. Alpha Cognition ACOG public float $149M, Jun 30, 2025
  3. Adaptimmune Therapeutics ADAP
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Adaptive Biotechnologies ADPT public float $1.4B, Jun 30, 2025